Experienced healthcare leader with over 30 years of operational experience in various functional roles such as global business and product development, licensing and acquisitions, venture investment and commercial sales management.
Over 30 years experience in innovation and development of multiple market transforming products. Roles in primarily in R&D, also in marketing and general management, Jamey’s emphasis has been in creating solutions for patients with cardiac and vascular diseases.
More than 20 years of experience in healthcare across academic research labs, start ups, and Fortune 500 companies. In R&D and Business Development roles, she has focused on building strong cross-functional collaborations to develop and commercialize new medical devices and digital health technologies.
Over 30 years experience in the Engineering, Manufacturing, and Operations in the medical device and high-tech industries. Focused on providing leadership while successfully scaling businesses from conceptual phase to commercialization.
Experienced commercial leader with over 30 years of experience including roles as CEO, chief commercial officer, general manager, sales and marketing across the medical device, pharmaceutical and digital health sectors. Lance has also held leadership roles in Fortune 100 to early-stage companies.
Alice has 23 years of Accounting & Finance experience in the medical device field. Over the years, Alice has helped small to medium size businesses from setting up accounting framework to getting a company ready for merger/acquisition.
Susan has more than 30 years in operations, engineering and quality leadership roles in the medical device industry. Susan’s previous role was the Divisional Vice President, Quality Assurance and Compliance, Abbott Cardiovascular Neuromodulation.
Truvic is a fast-paced medical device company developing innovative technologies in peripheral thrombus management. We have recently merged into Imperative Care and closed on a $260 Million round of capital to advance innovation and accelerate commercialization. We continue to build our team and together, we aim to redefine the treatment and management of peripheral thrombus.
For any types of inquiries feel free to reach out through this form below. We will do our best to respond as promptly as possible.
